MeSH D000686 - amyloidosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Novast Laboratories | Colchicine, Probenecid | Probenecid Colchicine | 2008-05-13 | |||
| Mylan | Colchicine | Colchicine | 2019-09-16 | |||
| Sandoz | Colchicine, Probenecid | Probenecid Colchicine | 1982-01-01 | |||
| Merck & Co | Colchicine, Probenecid | Colbenemid | 1982-01-01 | |||
| Pfizer | Tafamidis | Vyndaqel | 2011-11-16 | $3,321 M | Y2023 | |
| Takeda | Colchicine | Colcrys | 2028-10-06 | 2009-07-29 | ||
| Aurobindo Pharma | Colchicine | Colchicine | 2022-01-06 | |||
| Dr Reddys Laboratories | Colchicine | Colchicine | 2019-09-06 | |||
| Rising Pharmaceuticals | Acetylcysteine | Acetylcysteine | 2015-03-24 | |||
| Colchicine, Probenecid | Probenecid Colchicine | 2023-10-24 | ||||
| Zydus Therapeutics | Acetylcysteine | Acetylcysteine | 2018-07-20 | |||
| Colchicine | Colchicine | 2019-02-19 |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
83%19/23
Phase 2
36%10/28
Phase 3
26%5/19
Approved: 4Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use